Clinical Trial Update: A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging [Phase 2]

View source ↗

Summary

This is a Phase II optimization study of BMS068645 with sestamibi planar imaging. The study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Ischemic Heart Disease

Drugs mentioned

• BMS068645
• Sestamibi (Technetium-99m sestamibi)

Snippet

Sponsor: Forest Laboratories | Conditions: Cardiovascular Disease, Ischemic Heart Disease | Phase 2 | Status: TERMINATED